Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation

作者: Sujay Basu , Dinesh A Barawkar , Sachin Thorat , Yogesh D Shejul , Meena Patel

DOI: 10.1021/ACS.JMEDCHEM.6B01584

关键词: BioavailabilityAdenosine receptorChemistryADMESolubilityBenzothiazoleAntagonistIn vitroPharmacologyPharmacokinetics

摘要: Our initial structure–activity relationship studies on 7-methoxy-4-morpholino-benzothiazole derivatives featured by aryloxy-2-methylpropanamide moieties at the 2-position led to identification of compound 25 as a potent and selective A2A adenosine receptor (A2AAdoR) antagonist with reasonable ADME pharmacokinetic properties. However, poor intrinsic solubility low moderate oral bioavailability made this series unsuitable for further development. Further optimization using structure-based drug design approach resulted in discovery antagonists bearing substituted 1-methylcyclohexyl-carboxamide groups position 2 benzothiazole scaffold endowed better bioavailability. Compounds 41 49 demonstrated number positive attributes respect vitro Both compounds displayed good properties 63% 61% bioavailability, respectively, rat. Further, displa...

参考文章(34)
Qiaolin Deng, Yeon-Hee Lim, Rajan Anand, Younong Yu, Jae-hun Kim, Wei Zhou, Junying Zheng, Paul Tempest, Dorothy Levorse, Xiaoping Zhang, Scott Greene, Deborra Mullins, Chris Culberson, Brad Sherborne, Eric M. Parker, Andrew Stamford, Amjad Ali, Use of molecular modeling aided design to dial out hERG liability in adenosine A2A receptor antagonists Bioorganic & Medicinal Chemistry Letters. ,vol. 25, pp. 2958- 2962 ,(2015) , 10.1016/J.BMCL.2015.05.036
Elfatih Elzein, Rao V. Kalla, Xiaofen Li, Thao Perry, Art Gimbel, Dewan Zeng, David Lustig, Kwan Leung, Jeff Zablocki, Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases. Journal of Medicinal Chemistry. ,vol. 51, pp. 2267- 2278 ,(2008) , 10.1021/JM7014815
Bertil B. Fredholm, Giulia Arslan, Linda Halldner, Björn Kull, Gunnar Schulte, Ulrika Ådén, Per Svenningsson, Adenosine receptor signaling in vitro and in vivo Drug Development Research. ,vol. 52, pp. 274- 282 ,(2001) , 10.1002/DDR.1124
Manuel de Lera Ruiz, Yeon-Hee Lim, Junying Zheng, Adenosine A2A Receptor as a Drug Discovery Target Journal of Medicinal Chemistry. ,vol. 57, pp. 3623- 3650 ,(2014) , 10.1021/JM4011669
Kui Xu, Elena Bastia, Michael Schwarzschild, Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease Pharmacology & Therapeutics. ,vol. 105, pp. 267- 310 ,(2005) , 10.1016/J.PHARMTHERA.2004.10.007
Richard A. Friesner, Jay L. Banks, Robert B. Murphy, Thomas A. Halgren, Jasna J. Klicic, Daniel T. Mainz, Matthew P. Repasky, Eric H. Knoll, Mee Shelley, Jason K. Perry, David E. Shaw, Perry Francis, Peter S. Shenkin, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry. ,vol. 47, pp. 1739- 1749 ,(2004) , 10.1021/JM0306430
Sarmila Dasgupta, Sergi Ferré, Björn Kull, Peter B. Hedlund, Ulla-Britt Finnman, Susanne Ahlberg, Ernest Arenas, Bertil B. Fredholm, Kjell Fuxe, Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells European Journal of Pharmacology. ,vol. 316, pp. 325- 331 ,(1996) , 10.1016/S0014-2999(96)00665-6
Deborah H. Slee, Xiaohu Zhang, Manisha Moorjani, Emily Lin, Marion C. Lanier, Yongsheng Chen, Jaimie K. Rueter, Sandra M. Lechner, Stacy Markison, Siobhan Malany, Tanya Joswig, Mark Santos, Raymond S. Gross, John P. Williams, Julio C. Castro-Palomino, María I. Crespo, Maria Prat, Silvia Gual, José-Luis Díaz, Jenny Wen, Zhihong O’Brien, John Saunders, Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy. Journal of Medicinal Chemistry. ,vol. 51, pp. 400- 406 ,(2008) , 10.1021/JM070623O